|
ECONOMIC &
COMMERCIAL SECTION Embassy
of Belarus in London Tel:
020 7938 1633 Fax:
020 7361 0005 Email:
uk@belembassy.org |
BELARUSIAN ECONOMY
& TRADE
Historical
outlook
Economic
Policy Investment Climate Foreign
Trade Sectors of Economy
|
MAJOR
BELARUSIAN CONCERNS
|
LIST OF
INTERNATIONAL TOURIST & SPORTS EVENTS |
|||||||||||||||||
|
BELARUSIAN
COMPANIES, ENTERPRISES
|
||||||||||||||||||||
|
FREE ECONOMIC ZONES
|
NATIONAL
CALENDAR OF EXHIBITION ARRANGEMENTS |
|||||||||||||||||||
|
Website
navigation
|
Republic of Belarus
|
Embassy Home
|
News & Events
|
Press Releases
|
Commercial Section
|
Cultural & Humanitarian
Section
|
Consular & Visa Section
|
Contacts & Location
|
Site Map
|
|||||||||||
pharmaceuticals
|
Choose a
topic: Agriculture Automotive Banking &
Finance
Budget Building &
Construction
|
|
|||||||||||||||||||
|
|
24/02/2005 Belmedpreparaty
to start 3.4 mln euro pill production upgrade in ‘05
MINSK, Feb 23 (Prime-Tass) -- Belarus’ state company Belmedpreparaty, a
producer of pharmaceutical goods, based in Minsk, plans to start in 2005 a
3.4 million euro upgrade of its pill production facilities to receive a Good
Manufacturing Practice (GMP) certificate and promote its products on foreign
markets, a source with the administration of the company told Prime-Tass
Tuesday. The project is on the list of key investment
projects of the country, and is to be carried out by the end of 2006. The
upgrade is financed from Belarusbank’s loans. The current capacity of the company is at 1 billion
pills a year, and it is likely to remain the same after the upgrade. The key
task is to introduce new technologies compatible with the GMP standards, the
source said. Earlier, the company drafted a U.S. $22 million
business plan, which had to be given up after Belmedpreparaty decided not to
construct a new building. Last spring the Belarusian government approved as
the basis the state program of improvement of quality and increase in the
competitive ability of export oriented Belarus-made goods for 2004-2006. It
was planned to step up the operation of Belarus’ food industry, which
products are to be in full conformity with the international Hazard Analysis
and Critical Control Point (HACCR) standards, while Belarus’ pharmaceutics
should conform to GMP standards. Specialists believe the upgrade is important for
Belarus not to lose its position on the Russian market, which has introduced the
GMP conformance requirement regarding supplies of medicines for state needs.
Some specialists believe Belmedpreparaty launches the upgrade too late to
retain its position on the Russian market. Belmedpreparaty was founded in 1929 and transformed
into a joint stock company in 1995. In 2004 it became a state-owned company
again. Belmedpreparaty produces 300 medicines and blood substitutes. The
company exports half of its output. In 2004 the company started registering
its products in the European Union. End |
|
|||||||||||||||||||
|
|
|
|
|
||||||||||||||||||